REQUEST A DEMO
Total
USD $0.00
View basket Checkout now
Search more companies

Dr. Reddy'S Laboratories Malaysia Sdn. Bhd. (Malaysia)

Main Activities: Drugs and Druggists' Sundries Merchant Wholesalers
Full name: Dr. Reddy'S Laboratories Malaysia Sdn. Bhd. Profile Updated: February 05, 2024
Buy our report for this company USD 29.95 Most recent financial data: 2022 Available in: English Download a sample report

To carry on sales and marketing activities of pharmaceutical formulations and the business of domestic and international wholesale trade including import and export of pharmaceutical and medical related goods and products

Headquarters
Unit 10-06, Level 10, Menara Mbmr, No.1, Jalan Syed Putra
Kuala Lumpur; Federal Territories; Postal Code: 58000

Contact Details: Purchase the Dr. Reddy'S Laboratories Malaysia Sdn. Bhd. report to view the information.

Basic Information
Outstanding Shares:
Purchase the Dr. Reddy'S Laboratories Malaysia Sdn. Bhd. report to view the information.
Financial Auditors:
Purchase the Dr. Reddy'S Laboratories Malaysia Sdn. Bhd. report to view the information.
Incorporation Date:
July 10, 2017
Key Executives
Purchase this report to view the information.
Director
Purchase this report to view the information.
Director
Purchase this report to view the information.
Director
Purchase this report to view the information.
Director
Purchase this report to view the information.
Secretary
Ownership Details
Purchase this report to view the information.
100%
Company Performance
Financial values in the chart are available after Dr. Reddy'S Laboratories Malaysia Sdn. Bhd. report is purchased.
Looking for more than just a company report?

EMIS company profiles are part of a larger information service which combines company, industry and country data and analysis for over 145 emerging markets.

Request a demo of the EMIS service
Key Financial Highlights
Annual growth percentages for latest two years in local currency MYR. Absolute financial data is included in the purchased report.
Net sales revenue
48.51%▲
Total operating revenue
48.51%▲
Operating profit (EBIT)
76.06%▲
EBITDA
53.28%▲
Net Profit (Loss) for the Period
86.16%▲
Total assets
27.35%▲
Total equity
24.05%▲
Operating Profit Margin (ROS)
0.95%▲
Net Profit Margin
0.97%▲
Return on Equity (ROE)
6.47%▲
Quick Ratio
-0.06%▼
Cash Ratio
-0.02%▼

To view more information, Request a demonstration of the EMIS service

USD 29.95
Buy this company report
Need ongoing access to company, industry or country information?
Request a demo